Untitled
US$ 25.80
foxo4 dri peptide senolytic 2024 D-Retro-Inverso(DRI) Peptide inhibitors targeting FOXO4-p53 interactions
Description
Third-party tested - see Certificate of Analysis in product images
Flush IV lines when sterile conditions are required
Purity: 98% (HPLC) COA available upon request
Form: Lyophilised white powder
The optional Precision Peptide Genetic Test analyzes 17 Longevity insights including FOXO3 the most-studied longevity gene, linked to centenarian populations and cellular repair capacity with crossover into Energy Metabolism, Tissue Repair, and Cognition pathways
